Capricor Therapeutics (CAPR) Misses Q3 EPS by 2c

November 11, 2016 6:10 AM EST
Get Alerts CAPR Hot Sheet
Trade CAPR Now!
Join SI Premium – FREE

Get the Pulse of the Market with StreetInsider.com's Pulse Picks. Get your Free Trial here.

Capricor Therapeutics (NASDAQ: CAPR) reported Q3 EPS of ($0.29), $0.02 worse than the analyst estimate of ($0.27).

For earnings history and earnings-related data on Capricor Therapeutics (CAPR) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Earnings

Related Entities

Earnings

Add Your Comment